21 CFR § 862.1117 Clinical Chemistry and Clinical Toxicology Devices

§ 862.1117 B-type natriuretic peptide test system.

Current through Sep 8, 2026 · Read all of Part 862

⚠ 2 pending changes to Part 862

(a) Identification. The B-type natriuretic peptide (BNP) test system is an in vitro diagnostic device intended to measure BNP in whole blood and plasma. Measurements of BNP are used as an aid in the diagnosis of patients with congestive heart failure.

(b) Classification. Class II (special controls). The special control is “Class II Special Control Guidance Document for B-Type Natriuretic Peptide Premarket Notifications; Final Guidance for Industry and FDA Reviewers.”

[66 FR 12734, Feb. 28, 2001]

← § 862.1115 Urinary bilirubin and its conjugates (nonquantitative) test system.§ 862.1118 Biotinidase test system. →